Earlier studies described a high frequency of mutations and deletions in CYLD, TRAF3, and NFKBIA, whereas in EBV‐ NPC, the rate of mutation and copy number variations (CNVs) of NF‐κB pathway related were lower than in previous studies (Figure 1A). The gene discussed is CYLD; the disease is nasopharyngeal carcinoma.